vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Hilltop Holdings Inc. (HTH). Click either name above to swap in a different company.
Hilltop Holdings Inc. is the larger business by last-quarter revenue ($300.5M vs $185.2M, roughly 1.6× AMICUS THERAPEUTICS, INC.). Hilltop Holdings Inc. runs the higher net margin — 13.0% vs 0.9%, a 12.1% gap on every dollar of revenue. Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 0.6%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Hilltop Holdings Inc. is a financial holding company based in Dallas, Texas. It offers financial products and banking services through three primary subsidiaries: PlainsCapital Bank, PrimeLending, and HilltopSecurities.
FOLD vs HTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $300.5M |
| Net Profit | $1.7M | $39.0M |
| Gross Margin | 85.7% | — |
| Operating Margin | 8.6% | — |
| Net Margin | 0.9% | 13.0% |
| Revenue YoY | 23.7% | — |
| Net Profit YoY | -88.5% | -12.4% |
| EPS (diluted) | $0.00 | $0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $300.5M | ||
| Q4 25 | $185.2M | $329.9M | ||
| Q3 25 | $169.1M | $330.2M | ||
| Q2 25 | $154.7M | $303.3M | ||
| Q1 25 | $125.2M | $318.5M | ||
| Q4 24 | $149.7M | $301.1M | ||
| Q3 24 | $141.5M | $305.5M | ||
| Q2 24 | $126.7M | $297.0M |
| Q1 26 | — | $39.0M | ||
| Q4 25 | $1.7M | $41.6M | ||
| Q3 25 | $17.3M | $45.8M | ||
| Q2 25 | $-24.4M | $36.1M | ||
| Q1 25 | $-21.7M | $42.1M | ||
| Q4 24 | $14.7M | $35.5M | ||
| Q3 24 | $-6.7M | $29.7M | ||
| Q2 24 | $-15.7M | $20.3M |
| Q1 26 | — | — | ||
| Q4 25 | 85.7% | — | ||
| Q3 25 | 88.5% | — | ||
| Q2 25 | 90.2% | — | ||
| Q1 25 | 90.7% | — | ||
| Q4 24 | 90.1% | — | ||
| Q3 24 | 90.6% | — | ||
| Q2 24 | 91.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | 16.1% | ||
| Q3 25 | 20.3% | 18.4% | ||
| Q2 25 | -6.1% | 16.3% | ||
| Q1 25 | -6.3% | 18.1% | ||
| Q4 24 | 10.7% | 14.7% | ||
| Q3 24 | 15.3% | 13.9% | ||
| Q2 24 | 11.8% | 10.0% |
| Q1 26 | — | 13.0% | ||
| Q4 25 | 0.9% | 12.6% | ||
| Q3 25 | 10.2% | 13.9% | ||
| Q2 25 | -15.8% | 11.9% | ||
| Q1 25 | -17.3% | 13.2% | ||
| Q4 24 | 9.8% | 11.8% | ||
| Q3 24 | -4.8% | 9.7% | ||
| Q2 24 | -12.4% | 6.8% |
| Q1 26 | — | $0.64 | ||
| Q4 25 | $0.00 | $0.68 | ||
| Q3 25 | $0.06 | $0.74 | ||
| Q2 25 | $-0.08 | $0.57 | ||
| Q1 25 | $-0.07 | $0.65 | ||
| Q4 24 | $0.05 | $0.55 | ||
| Q3 24 | $-0.02 | $0.46 | ||
| Q2 24 | $-0.05 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | — |
| Total DebtLower is stronger | $392.7M | $990.8M |
| Stockholders' EquityBook value | $274.2M | $2.2B |
| Total Assets | $949.9M | $15.7B |
| Debt / EquityLower = less leverage | 1.43× | 0.46× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $293.5M | — | ||
| Q3 25 | $263.8M | — | ||
| Q2 25 | $231.0M | — | ||
| Q1 25 | $250.6M | — | ||
| Q4 24 | $249.9M | — | ||
| Q3 24 | $249.8M | — | ||
| Q2 24 | $260.1M | — |
| Q1 26 | — | $990.8M | ||
| Q4 25 | $392.7M | — | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | — | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $274.2M | $2.2B | ||
| Q3 25 | $230.4M | $2.2B | ||
| Q2 25 | $204.3M | $2.2B | ||
| Q1 25 | $193.6M | $2.2B | ||
| Q4 24 | $194.0M | $2.2B | ||
| Q3 24 | $178.8M | $2.2B | ||
| Q2 24 | $132.5M | $2.1B |
| Q1 26 | — | $15.7B | ||
| Q4 25 | $949.9M | $15.8B | ||
| Q3 25 | $868.8M | $15.6B | ||
| Q2 25 | $815.3M | $15.4B | ||
| Q1 25 | $789.8M | $15.8B | ||
| Q4 24 | $785.0M | $16.3B | ||
| Q3 24 | $786.6M | $15.9B | ||
| Q2 24 | $749.5M | $15.6B |
| Q1 26 | — | 0.46× | ||
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | — |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $16.3M | $-38.7M | ||
| Q3 25 | $35.7M | $273.0M | ||
| Q2 25 | $-26.5M | $-234.6M | ||
| Q1 25 | $7.8M | $5.8M | ||
| Q4 24 | $-3.9M | $273.9M | ||
| Q3 24 | $-23.0M | $515.6M | ||
| Q2 24 | $22.7M | $-435.3M |
| Q1 26 | — | — | ||
| Q4 25 | $16.0M | $-55.5M | ||
| Q3 25 | $35.3M | $271.0M | ||
| Q2 25 | $-28.9M | $-234.6M | ||
| Q1 25 | $7.5M | $5.0M | ||
| Q4 24 | $-4.2M | $266.8M | ||
| Q3 24 | $-23.3M | $513.8M | ||
| Q2 24 | $21.6M | $-437.3M |
| Q1 26 | — | — | ||
| Q4 25 | 8.6% | -16.8% | ||
| Q3 25 | 20.9% | 82.1% | ||
| Q2 25 | -18.7% | -77.4% | ||
| Q1 25 | 6.0% | 1.6% | ||
| Q4 24 | -2.8% | 88.6% | ||
| Q3 24 | -16.5% | 168.2% | ||
| Q2 24 | 17.0% | -147.2% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 5.1% | ||
| Q3 25 | 0.2% | 0.6% | ||
| Q2 25 | 1.6% | 0.0% | ||
| Q1 25 | 0.2% | 0.3% | ||
| Q4 24 | 0.2% | 2.4% | ||
| Q3 24 | 0.3% | 0.6% | ||
| Q2 24 | 0.9% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 9.62× | -0.93× | ||
| Q3 25 | 2.06× | 5.96× | ||
| Q2 25 | — | -6.50× | ||
| Q1 25 | — | 0.14× | ||
| Q4 24 | -0.27× | 7.71× | ||
| Q3 24 | — | 17.36× | ||
| Q2 24 | — | -21.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
HTH
| Noninterest Income | $188.4M | 63% |
| Net Interest Income | $112.1M | 37% |
